/PRNewswire/ Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published the.
/PRNewswire/ Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and.
RADx expands COVID-19 home and point-of-care testing, wastewater surveillance
Four contracts awarded for over $65 million
Minute Molecular Diagnostics
Among the new technologies being supported by RADx Tech to scale up manufacturing of COVID-19 tests are a 15-minute RT-PCR test for use at the point-of-care from Minute Molecular Diagnostics. The test is being further developed for an over the counter test.
Newswise The National Institutes of Health (NIH) today announced three new contracts and one new award to an existing contract for scale-up and manufacturing of novel COVID-19 testing technologies. The four Rapid Acceleration of Diagnostics (RADx
SM) initiative contracts total $65.6 million for home and point-of-care testing and the development and implementation of wastewater-based surveillance systems.